Trial intelligence / Profile preview

Prasugrel Dose Adjustment in Asian ACS Patients

NCT01951001Phase 4Completed

Sponsor
Gyeongsang National University Hospital
Start
Jul 2013
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of prasugrel in acute coronary syndrome (ACS), sponsored by Gyeongsang National University Hospital. Started Jul 2013; status: completed.

02

Drugs

prasugrel
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT01951001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01951001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call